#United States #New York #Gross Law Firm #class action lawsuit #Immutep Limited

Immutep Limited Investors Alert: Class Action Lawsuit Information

On May 12, 2026, The Gross Law Firm issued an urgent statement for shareholders of Immutep Limited (NASDAQ: IMMP). The firm encourages all investors who purchased shares of IMMP between March 24, 2025, and March 12, 2026, to get in touch regarding possible lead plaintiff appointments in a class action lawsuit.

Background

This notice arises in the context of significant losses incurred by shareholders following troubling developments surrounding the company's TACTI-004 Phase III clinical study. The allegations state that Immutep's leadership made uniformly positive statements while hiding critical information about the efficacy and safety of their trial. Specifically, an Independent Data Monitoring Committee (IDMC) recommended discontinuing the trial based on a planned interim futility analysis, which became public knowledge on March 13, 2026.

Following this revelation, the stock price plummeted from $2.76 on March 12 to a mere $0.48 the next day, marking a devastating decline of approximately 83%. This significant drop reflects the adverse impact of the company’s earlier misleading statements, prompting individuals to consider legal recourse.

Legal Implications

The Gross Law Firm highlights the essential steps shareholders should take. The registration process ensures investors become part of the collective legal effort to recover losses. By registering, shareholders will be added to a portfolio monitoring system that will update them throughout the case’s lifecycle.

Additionally, shareholders must act promptly, as the deadline for seeking lead plaintiff status is July 6, 2026. Importantly, registering to participate in the class action entails no financial obligation or costs, making it an accessible option for those affected.

Why Choose Gross Law Firm?

The Gross Law Firm is renowned for its commitment to investor rights and its vigorous pursuit of accountability in corporate practices. With a mission to shield investors from fraudulent behaviors and false representations, the firm aims to ensure that companies adhere to ethical standards.

With their established track record and deep expertise in securities litigation, Gross Law Firm positions itself as a trustworthy ally for shareholders affected by the alleged misconduct of Immutep Limited.

For further details and registration, interested parties can visit the official law firm link.

Conclusion

Shareholders of Immutep Limited are urged to take these developments seriously and to actively participate in the class action lawsuit process to achieve justice and potential financial recovery for their losses. The Gross Law Firm remains open to queries and assistance as individuals navigate this challenging situation. Investors are encouraged to reach out to the firm directly, either by calling (646) 453-8903 or visiting their website for more information.